Back to the future
Technology of the past 100 years has one big obsession, namely using fossil fuels – whether it makes sense or not. Electric vehicles and trains were around at the beginning of the 20th century, but most were replaced by petrol and diesel engines. Earlier technologies like sail ships and windmills were confined to the heritage sector.
Living with viruses
The author of this volume, Tom Ireland, is a widely published freelance science journalist and currently editor of The Biologist magazine. This work has the prime purpose of convincing us that not all viruses are harmful, and that the vast majority are actually beneficial.
The Discovery of Natural Selection
The author of this work, James Costa, is currently Professor of biology and Executive Director of the Highlands Biological Station at Western Carolina University, US. An enduring fascination for the origins of the theory of evolution has resulted in his publication of several scholarly books on the subject, including Wallace, Darwin, and the Origin of Species.
On the origins of antimicrobial resistance
How does antibiotic resistance emerge? Anthony King discovers that the conventional narrative doesn't tell the whole story.
Green catalysts: catalysing sustainability
Fundamental research is helping to drive the development of a new generation of catalysts that should accelerate progress towards global sustainability goals. Lou Reade reports.
UK plans for pharma price control
UK Government’s plans to amend a scheme that controls the prices of branded medicines for the NHS has drawn fire from the pharmaceutical industry. It warns that some proposals are likely to reduce patient access to medicines, harm UK clinical research, and undermine investment in UK life sciences.
Business digest
The latest business digest for C&I Issue 11 2023 with all the latest mergers and acquisitions in the chemical industry.
New UK funding being offered to combat AMR
Innovate UK has joined with medical research organisation LifeArc and Medicines Discovery Catapult to accelerate early-stage innovation in antimicrobial resistance (AMR). Innovate UK and LifeArc have each invested £15m in PACE (Pathways to Antimicrobial Clinical Efficiency), which will be delivered by the Medicines Discovery Catapult.
Like flu-less chickens
Researchers have used gene editing techniques to limit the spread of bird flu in chickens, although further gene edits would be needed to produce chickens resistant to the disease.